News tagged with metformin


M. D. Anderson study finds common diabetic therapy reduces risk of pancreatic cancer

Common diabetic therapy reduces risk of pancreatic cancer, study finds

Medicine & Health / Cancer

created Aug 01, 2009 | popularity 5 / 5 (4) | comments 0

Taking the most commonly-prescribed anti-diabetic drug, metformin, reduces an individual's risk of developing pancreatic cancer by 62 percent, according to research from The University of Texas M. D. Anderson ...


Old diabetes drug teaches experts new tricks

Medicine & Health / Research

created May 14, 2009 | popularity 5 / 5 (2) | comments 0

Research from the Johns Hopkins Children's Center reveals that the drug most commonly used in type 2 diabetics who don't need insulin works on a much more basic level than once thought, treating persistently elevated blood ...





Search results for metformin


Popular diabetes drugs linked to increased risk of heart failure and death

Medicine & Health / Medications

created Dec 04, 2009 | popularity 5 / 5 (2) | comments 0

Sulphonylureas, a type of drug widely used to treat type 2 diabetes, carries a greater risk of heart failure and death compared with metformin, another popular antidiabetes drug.


Lifestyle changes may stave off diabetes for a decade

Medicine & Health / Health

created Nov 02, 2009 | popularity not rated yet | comments 0

Sustaining modest weight loss for 10 years, or taking an anti-diabetic drug over that time, can prevent or lower the incidence of type 2 diabetes in people at high risk for developing the disease, according to the Diabetes ...


Lifestyle changes, drug lower type 2 diabetes risk

Medicine & Health / Health

created Oct 28, 2009 | popularity 5 / 5 (2) | comments 0

Intensive lifestyle changes aimed at modest weight loss reduced the rate of developing type 2 diabetes by 34 percent over 10 years in people at high risk for the disease.


Bristol-Myers gets EU approval for diabetes drug

Medicine & Health / Medications

created Oct 05, 2009 | popularity not rated yet | comments 0

(AP) -- Drugmaker Bristol-Myers Squibb Co. said Monday that its new diabetes drug, Onglyza, has been approved for sale in the European Union's 27 countries.


Lab mice

Longer-lived, healthier mice offer promise of drug treatments for age-related diseases

Medicine & Health / Research

created Oct 01, 2009 | popularity 4.7 / 5 (9) | comments 0

Scientists have managed to extend the lifespan of mice by up to a fifth and reduce the number of age-related diseases the animals suffer. The research, which involved blocking a key molecular pathway, mimics ...


Insulin, metformin do not reduce inflammatory biomarkers for diabetes patients

Medicine & Health / Research

created Sep 15, 2009 | popularity 4 / 5 (1) | comments 0

In patients with recent onset type-2 diabetes, treatment with insulin or the diabetes drug metformin did not reduce inflammatory biomarkers, such as high-sensitivity C-reactive protein, although the treatment did improve ...


Diabetes drug kills cancer stem cells in combination treatment in mice

Medicine & Health / Cancer

created Sep 14, 2009 | popularity 5 / 5 (3) | comments 0

In a one-two punch, a familiar diabetes drug reduced tumors faster and prolonged remission in mice longer than chemotherapy alone by targeting cancer stem cells, Harvard Medical School researchers reported in the September ...


Physicians bust myths about insulin

Physicians bust myths about insulin

Medicine & Health / Research

created Aug 11, 2009 | popularity not rated yet | comments 3

People diagnosed with type 2 diabetes often resist taking insulin because they fear gaining weight, developing low blood sugar and seeing their quality of life decline.


Benefit of glinides is not proven

Medicine & Health / Other

created Jun 18, 2009 | popularity not rated yet | comments 0

The benefit of glinides in the treatment of type 2 diabetes is not scientifically proven. Nor do they perform better than other antidiabetics available in tablet form, such as metformin and sulfonylureas. As a result, there ...


Rosiglitazone does not harm bone healing if combined with metformin in rats

Medicine & Health / Research

created Jun 11, 2009 | popularity not rated yet | comments 0

Taking the diabetes medications metformin and rosiglitazone together reverses the adverse effects on bone of rosiglitazone treatment alone in an experimental model, according to a new study done in rats.



List of search results for metformin